MANUEL
DELGADO ALVARADO
Investigador hasta 2022
Hospital Sierrallana
Torrelavega, EspañaPublicaciones en colaboración con investigadores/as de Hospital Sierrallana (18)
2023
-
A novel clinical sign to assess the risk of Parkinson’s disease in patients with isolated asymmetric arm swing
Neurological Sciences, Vol. 44, Núm. 4, pp. 1401-1404
-
Interactions between functional networks in Parkinson's disease mild cognitive impairment
Scientific Reports, Vol. 13, Núm. 1
-
Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study
Frontiers in Immunology, Vol. 14
2022
-
Neurogenetic traits outline vulnerability to cortical disruption in Parkinson's disease
NeuroImage: Clinical, Vol. 33
-
Teriflunomide-induced Raynaud’s phenomenon: a serious adverse event, previously unreported
Neurological Sciences
2021
-
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12
-
Predictive value of prolactin in first episode psychosis at ten years follow-up
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 179-180
2020
-
A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability
Neurological Sciences, Vol. 41, Núm. 12, pp. 3779-3781
-
Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)
Psychopharmacology
-
Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders
Parkinsonism and Related Disorders, Vol. 70, pp. 74-81
-
Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease
Movement Disorders, Vol. 35, Núm. 2, pp. 316-325
-
Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats
Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431
-
Nonpharmacological, nonsurgical treatments for freezing of gait in Parkinson's disease: A systematic review
Movement Disorders, Vol. 35, Núm. 2, pp. 204-214
2019
-
Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, Núm. 10, pp. 2065-2076
-
Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients
Archives of Women's Mental Health, Vol. 22, Núm. 3, pp. 367-373
2018
-
Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study
Movement Disorders, Vol. 33, Núm. 11, pp. 1809-1813
2017
-
Bone Health in Parkinson’s Disease
Clinical Reviews in Bone and Mineral Metabolism, Vol. 15, Núm. 3, pp. 99-114